Trial
NCT04480879
Evaluation of AZD8154 Concentrations in Blood
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
AstraZeneca
Collaborators
Parexel
Condition
Asthma
Intervention
AZD8154 nebuliser
Why stopped
Need for evaluation of emerging pre-clinical toxicology findings
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-08-24